comparemela.com

Page 9 - ஜெஃப் எவன்ஸ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Family, hospital staff recalls moment baby was born in car during Winter Storm Cooper

NORWICH, CT (WFSB) – A baby was born in the front seat of her parent’s car during Winter Storm Cooper on Monday. Hartford HealthCare said Kaitlyn Vacchina of Lebanon unexpectedly delivered her baby in the front seat of her car as they pulled up at the Backus Hospital Emergency Department on Monday. Kaitlyn’s husband David said he ran into the emergency department and shouted his wife was having a baby. I ran into the emergency room, my wife s in labor, we re having a baby. When I get out there, her pants are down and I see a baby s head crowning, David said. 

Milton Riverfront is Lit

January 18, 2021 Jeff Evans is one of many Miltonians who’ve been enjoying the town’s cool new riverfront scene, accentuated by lights from Irish Eyes at left, and the newly opened Dough Bar and its unique “dough balls,” clear heated tents that can seat from four to six people. Photographers should submit work to photos@capegazette.com for consideration in the Community Photography Showcase online feature. Please include your name, phone number and where the photo was made. Photos will be posted to www.capegazette.com/column/community-photo-showcase.

Community Calendar — Jan 23-Feb 25

Bowlero opening in Boca Raton - South Florida Sun-Sentinel

Medivir presents MIV-818 data at ASCO Gastrointestinal Cancers Symposium

Share this article STOCKHOLM, Jan. 12, 2021 /PRNewswire/ Medivir AB (Nasdaq Stockholm: MVIR) today announces that a presentation entitled Phase I study of the novel pro-drug MIV-818 in patients with hepatocellular carcinoma, intra-hepatic cholangiocarcinoma or liver metastases will be given by Professor Jeff Evans, Director of Institute of Cancer Sciences at University of Glasgow, at the virtual ASCO Gastrointestinal Cancers Symposium (ASCO-GI). The presentation will be given on January 15, 2021, at 2 pm CET during the Hepatobiliary Cancer session (presentation number 309).  The results from the completed phase Ia intra-patient dose escalation part of the study show that MIV-818 has an acceptable safety and tolerability profile and a selective effect on liver cancer cells. The inter-patient dose escalation phase Ib part is currently ongoing at a dose of 40 mg for 5 days in 21-day cycles. 

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.